tyrosine has been researched along with Anemia, Sickle Cell in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (23.81) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hausman, JM; Kalfa, T; Low, PS; Noomuna, P; Risinger, M; Sansoya, R | 1 |
| Gibson, JS | 1 |
| Burnett, AL; Chen, H; Karakus, S; La Favor, JD; Musicki, B; Silva, FH; Sturny, M; Zirkin, BR | 1 |
| Antoine-Jonville, S; Bloch, W; Charlot, K; Collins, B; Connes, P; Etienne-Julan, M; Grau, M; Hardy-Dessources, MD; Jumet, S; Lamarre, Y; Lemonne, N; Mozar, A; Romana, M; Suhr, F; Weyel, L | 1 |
| Knee, KM; Mukerji, I | 1 |
| Antmen, B; Aslan, M; Celmeli, G; Dogan, S; Kupesiz, A | 1 |
| Alexander, CB; Aslan, M; Barnes, S; Coward, L; Freeman, BA; Kirk, MC; Rosenfeld, SS; Ryan, TM; Townes, TM | 1 |
| Ackland-Berglund, C; Franciosi, JP; Guice, KS; Hillery, CA; Holzhauer, S; Kaul, S; Mohandas, N; Oldham, KT; Ou, J; Ou, Z; Pritchard, KA; Shi, Y; Signorino, P; Witte, K | 1 |
| Chang, HY; Fabry, ME; Kaul, DK; Liu, XD; Nagel, RL | 1 |
| Badaloo, A; Forrester, T; Jahoor, F; Reid, M | 1 |
| Dasgupta, T; Fabry, ME; Kaul, DK; Zhang, X | 1 |
| Gladwin, MT; Hsu, LL; Krajewski, ML | 1 |
| Mamunes, P | 1 |
| Goldberg, A; McColl, KE | 1 |
| Giraud, F; Hardy-Dessources, MD; Merciris, P; Sauvage, M | 1 |
| Carvalho, CR; Costa, FF; Saad, MJ; Saad, ST; Terra, HT; Vicentin, DL | 1 |
| Ahmed, F; Anthony, GM; Bank, N; Fabry, ME; Kiroycheva, M; Nagel, RL; Singhal, PC | 1 |
| Anthony, GM; Bank, N; Kiroycheva, M; Singhal, PC; Southan, GJ; Szabo, C | 1 |
| Rigilano, JC; Stevens, MB; Wilson, CC | 1 |
| Levy, HL | 1 |
| Balda, BR; Lukacs, I | 1 |
3 review(s) available for tyrosine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Neonatal screening tests.
Topics: Adenosine Deaminase; Anemia, Sickle Cell; Biological Assay; Costs and Cost Analysis; Galactosemias; Histidine; Homocystinuria; Humans; Infant, Newborn; Maple Syrup Urine Disease; Mass Screening; Metabolism, Inborn Errors; Phenylalanine; Phenylketonurias; Tyrosine; United States | 1980 |
Genetic screening.
Topics: Amino Acid Metabolism, Inborn Errors; Anemia, Sickle Cell; Arginine; Carbohydrate Metabolism, Inborn Errors; Cystinuria; Erythrocytes; Fanconi Syndrome; Galactosemias; Genetics, Population; Glucosephosphate Dehydrogenase; Glycine; Hartnup Disease; Heterozygote; Histidine; Homocystine; Humans; Lysine; Maple Syrup Urine Disease; Mass Screening; Methods; Ornithine; Phenylalanine; Phenylketonurias; Succinates; Tyrosine | 1973 |
[Molecular biologic aspects in dermatology demonstrated by some hereditary enzyme defects].
Topics: Albinism; Alkaptonuria; Anemia, Sickle Cell; Chromosomes; Hartnup Disease; Humans; Maple Syrup Urine Disease; Metabolism, Inborn Errors; Models, Chemical; Molecular Biology; Phenylalanine; Phenylketonurias; Porphyrias; Skin Diseases; Tyrosine | 1968 |
1 trial(s) available for tyrosine and Anemia, Sickle Cell
| Article | Year |
|---|---|
High red blood cell nitric oxide synthase activation is not associated with improved vascular function and red blood cell deformability in sickle cell anaemia.
Topics: Anemia, Sickle Cell; Enzyme Activation; Erythrocyte Deformability; Erythrocytes; Female; Humans; Male; Nitric Oxide Synthase; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Spectrin; Tyrosine | 2015 |
17 other study(ies) available for tyrosine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Rapid degradation of protein tyrosine phosphatase 1B in sickle cells: Possible contribution to sickle cell membrane weakening.
Topics: Anemia, Sickle Cell; Erythrocyte Membrane; Humans; Membrane Proteins; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Tyrosine | 2022 |
A novel mechanism for pathogenesis of sickle cell disease with therapeutic implications: Band 3 tyrosine phosphorylation.
Topics: Anemia, Sickle Cell; Anion Exchange Protein 1, Erythrocyte; Humans; Phosphorylation; Tyrosine | 2020 |
TSPO ligand FGIN-1-27 controls priapism in sickle cell mice via endogenous testosterone production.
Topics: Anemia, Sickle Cell; Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; Indoleacetic Acids; Luteinizing Hormone; Male; Mice, Transgenic; NADPH Oxidases; Nitric Oxide; Penis; Phosphorylation; Priapism; Receptors, GABA; Testis; Testosterone; Tyrosine | 2021 |
Real time monitoring of sickle cell hemoglobin fiber formation by UV resonance Raman spectroscopy.
Topics: Amino Acid Substitution; Anemia, Sickle Cell; Crystallography, X-Ray; Hemoglobin, Sickle; Hemolysis; Humans; Kinetics; Models, Molecular; Mutation; Phenylalanine; Protein Conformation; Protein Subunits; Spectrum Analysis, Raman; Tryptophan; Tyrosine | 2009 |
The effect of hemolysis on plasma oxidation and nitration in patients with sickle cell disease.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Bilirubin; Biomarkers; Child; Child, Preschool; Dinoprost; Erythrocyte Indices; Female; Haptoglobins; Hemoglobin A; Hemoglobin, Sickle; Hemolysis; Humans; Isoenzymes; L-Lactate Dehydrogenase; Male; Nitric Oxide; Oxidation-Reduction; Reticulocyte Count; Reticulocytes; Tyrosine | 2012 |
Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization.
Topics: Actins; Amino Acid Sequence; Anemia, Sickle Cell; Animals; Cytoskeleton; Humans; In Situ Nick-End Labeling; Kidney; Liver; Mice; Microscopy, Fluorescence; Molecular Sequence Data; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Reactive Oxygen Species; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tyrosine | 2003 |
Hypoxia-induced acute lung injury in murine models of sickle cell disease.
Topics: Acute Disease; Anemia, Sickle Cell; Animals; Disease Models, Animal; Hemoglobin, Sickle; HSP90 Heat-Shock Proteins; Humans; Hypoxia; Lung Diseases; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Tyrosine | 2004 |
Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.
Topics: Acetylcholine; Anemia, Sickle Cell; Animals; Cell Adhesion; Cyclooxygenase 2; Endothelium, Vascular; Enzyme Inhibitors; Female; Fetal Hemoglobin; Hemodynamics; Hemoglobin, Sickle; Hemolysis; Humans; Isoenzymes; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microcirculation; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroprusside; Oxidative Stress; Prostaglandin-Endoperoxide Synthases; Tyrosine; Vasodilation; Vasodilator Agents | 2004 |
In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Creatinine; Cysteine; Eating; Erythrocytes; Female; Glutathione; Glutathione Disulfide; Glycine; Humans; Hydrogen Peroxide; Isoprostanes; Male; Statistics, Nonparametric; Tyrosine | 2006 |
Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.
Topics: Acetylcholine; Anemia, Sickle Cell; Animals; Arginine; Citrulline; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Enzyme Inhibitors; Globins; Heme Oxygenase-1; Hemodynamics; Hemoglobins; Hemolysis; Humans; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroprusside; Oxidative Stress; Tyrosine; Vasodilator Agents | 2008 |
The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology.
Topics: Anemia, Sickle Cell; Animals; Arginine; Disease Models, Animal; Hemodynamics; Hemoglobins; Hemolysis; Humans; Microcirculation; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Oxidative Stress; Tyrosine; Vasodilator Agents | 2008 |
Abnormal porphyrin metabolism in diseases other than prophyria.
Topics: Alcohol Drinking; Amino Acid Metabolism, Inborn Errors; Anemia, Hemolytic; Anemia, Hypochromic; Anemia, Megaloblastic; Anemia, Sickle Cell; Anemia, Sideroblastic; Humans; Lead Poisoning; Leukemia; Liver Diseases; Malabsorption Syndromes; Mental Disorders; Polycythemia; Porphyrins; Time Factors; Tyrosine | 1980 |
Involvement of deoxygenation-induced increase in tyrosine kinase activity in sickle cell dehydration.
Topics: Anemia, Sickle Cell; Biological Transport; Calcium; Catechols; Cinnamates; Enzyme Inhibitors; Erythrocytes; Humans; In Vitro Techniques; Nitriles; Oxygen; Phosphorylation; Potassium; Protein-Tyrosine Kinases; Tyrosine; Tyrphostins | 1998 |
Increased tyrosine phosphorylation of band 3 in hemoglobinopathies.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Anion Exchange Protein 1, Erythrocyte; Antibodies; beta-Thalassemia; Erythrocyte Count; Erythrocytes; Hemoglobin SC Disease; Hemoglobinopathies; Humans; Immunoblotting; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Reticulocytes; Tyrosine; Vanadates | 1998 |
Peroxynitrite formation and apoptosis in transgenic sickle cell mouse kidneys.
Topics: Anemia, Sickle Cell; Animals; Apoptosis; Blotting, Western; Immunohistochemistry; Kidney; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Tyrosine | 1998 |
Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys.
Topics: Alanine Transaminase; Anemia, Sickle Cell; Animals; Apoptosis; Aspartate Aminotransferases; Blotting, Western; Cell Hypoxia; DNA Fragmentation; Electrophoresis, Agar Gel; Enzyme Inhibitors; Guanidines; Immunohistochemistry; In Situ Nick-End Labeling; Kidney Diseases; Kidney Tubules; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Poly(ADP-ribose) Polymerases; Tyrosine | 2000 |
State screening for metabolic disorders in newborns.
Topics: Adrenal Hyperplasia, Congenital; Amidohydrolases; Amino Acid Metabolism, Inborn Errors; Anemia, Sickle Cell; Biotinidase; Congenital Hypothyroidism; Cystic Fibrosis; Galactosemias; Homocystinuria; Humans; Hypothyroidism; Infant, Newborn; Maple Syrup Urine Disease; Mass Screening; Metabolism, Inborn Errors; Phenylketonurias; Tyrosine; United States | 1988 |